(Q35949113)

11 August 2017

Risk of fracture with thiazolidinediones: disease or drugs? (English)

1 reference

11 August 2017

1 reference

Frank de Vries

7

0 references

Cyrus Cooper

object named as

Cyrus Cooper

series ordinal

5

0 references

Arlene M Gallagher

series ordinal

3

object named as

Arlene M Gallagher

1 reference

11 August 2017

1

Marloes T Bazelier

1 reference

11 August 2017

2

Peter Vestergaard

1 reference

11 August 2017

4

Tjeerd-Pieter van Staa

1 reference

11 August 2017

6

Hubert G M Leufkens

1 reference

PMCID

3349019

11 August 2017

language of work or name

English

0 references

publication date

10 April 2012

1 reference

Calcified Tissue International

11 August 2017

1 reference

11 August 2017

90

1 reference

11 August 2017

6

1 reference

11 August 2017

450-457

1 reference

https://scigraph.springernature.com/pub.10.1007/s00223-012-9591-8

11 August 2017

0 references

cites work

Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examination Survey, 1999-2006

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

Cardiovascular risk and thiazolidinediones--what do meta-analyses really tell us?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

The risk of fractures associated with thiazolidinediones: a self-controlled case-series study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

A cohort study of thiazolidinediones and fractures in older adults with diabetes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

Use of thiazolidinediones and fracture risk

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

FRAX and the assessment of fracture probability in men and women from the UK

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

Skeletal consequences of thiazolidinedione therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

Skeletal involvement in patients with diabetes mellitus.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

Bone is a target for the antidiabetic compound rosiglitazone.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

The Danish National Hospital Register. A valuable source of data for modern health sciences.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

The national patient registry. Evaluation of data quality

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells

2 October 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9591-8

Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9591-8

Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9591-8

Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9591-8

Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9591-8

Vitamin D metabolites in diabetic patients: decreased serum concentration of 24,25-dihydroxyvitamin D

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349019

Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus

14 November 2018

1 reference

12 December 2020

Diabetic bone disease

1 reference

12 December 2020

Regulation of osteoclastic bone resorption by glucose

1 reference

12 December 2020

Impact of peripheral neuropathy on bone density in patients with type 1 diabetes

1 reference

12 December 2020

Increased fracture rate in diabetes mellitus and females after renal transplantation

1 reference

12 December 2020

Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways

1 reference

12 December 2020

10.1007/S00223-012-9591-8

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

1 reference

PMCID

3349019